Lycia Therapeutics Prices Upsized IPO at $18.00 Per Share

Key Facts

1Lycia Therapeutics priced its initial public offering at $18.00 per share.

2The offering was upsized to 17,640,000 shares of common stock.

Lycia Therapeutics priced its initial public offering at $18.00 per share, according to a statement released via GlobeNewswire. The company upsized the offering to 17,640,000 shares of common stock, indicating healthy investor demand for the biotech issuance.

The firm is transitioning to public markets to fund the clinical-stage development of therapeutics for autoimmune and inflammatory diseases. Lycia’s common stock is expected to begin trading on the Nasdaq Global Select Market under the symbol LYCA on October 23, 2026, with the offering scheduled to close on October 26, 2026.